Pulse 探索 nav.journalClub 辩论趋势研究者期刊

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

首页探索 nav.journalClub 趋势

⌘+K

Tesamorelin — Research & Evidence | Synapse

Topics/Tesamorelin

Tesamorelin — illustrative scientific rendering

Cardiology

Tesamorelin

Clinical and translational research on tesamorelin, an FDA-approved GHRH analog for HIV-associated lipodystrophy, and related metabolic studies.

Unknown pathwayAlso known as: Tesamorelin, Egrifta, GHRH analog HIV lipodystrophy

1

Clinical questions

0

Claims analyzed

Consensus New research Evidence brief

What does the research say about Tesamorelin?

Unknown pathwayBased on 0 claims ( agreements, contradictions)

No claims extracted for this topic

New research on Tesamorelin

Dose comparison study of pegylated interferon‐α‐2b plus ribavirin in naïve Japanese patients with hepatitis C virus genotype 2: A randomized clinical trial

Journal of Gastroenterology and Hepatology — Kawaoka T — Nov 2008

HTR1A, TPH2, and 5-HTTLPR Polymorphisms and Their Impact on the Severity of Depressive Symptoms and on the Concentration of Tryptophan Catabolites during Hepatitis C Treatment with Pegylated Interferon-α2a and Oral Ribavirin (PEG-IFN-α2a/RBV)

Cells — Pawłowski T — Mar 2023

Inborn errors of TLR3- or MDA5-dependent type I IFN immunity in children with enterovirus rhombencephalitis

The Journal of Experimental Medicine — Chen J — Nov 2021

Stay current on Tesamorelin

Follow this topic to get a weekly “what changed” evidence digest and alerts when journal clubs schedule sessions on it.

Evidence brief: Tesamorelin

Tesamorelin (also known as Tesamorelin, Egrifta, GHRH analog HIV lipodystrophy). Clinical and translational research on tesamorelin, an FDA-approved GHRH analog for HIV-associated lipodystrophy, and related metabolic studies.

As of 2026-08-14, the scientific consensus on Tesamorelin is unknown. No claims extracted for this topic

This evidence brief synthesizes Synapse's enriched cardiology corpus; cite as synapsesocial.com/topics/peptide-tesamorelin.

Deterministic synthesis from Synapse's enriched corpus — 54 words. No AI-generated novel content; every figure is sourced from the underlying paper, guideline, or trial record linked on this page.

Follow the latest Tesamorelin research

Explore every Tesamorelin paper on Synapse with AI-enriched clinical evidence, PICO analysis, and methodology classification.

Search Tesamorelin papers

Powered by Synapse — AI-enriched analysis of 600,000+ peer-reviewed papers